Home » Newsletters » BioWorld Asia

BioWorld Asia

July 28, 1999

View Archived Issues

Cerep, Bristol-Myers Align In Broad Deal Worth $43M

EU Debate, Confusion Continue Over Confined Use Of GMOs

Bacterium's Ability To Stimulate T Cells Could Lead To Vaccine

Ovarian Cancer Gene Therapy Enters Phase II/III in Germany

MolecularNature Focuses On Plant-Based Compounds

Canadian Start-Up Working On New Approach To Cancer

PPL Uses Gene Targeting To Produce Two Lambs

AdProTech Compound Shows Promise In Animal Models

Cortecs Gets Termination Milestone From Partner

Oxford Biomedica, Modex Enter Insulin-Delivery Deal

NiCox Starts Phase II Trial At Two Centers In France

Genset Isolates Genes Associated With Responses To Asthma Drug

Queensland Researchers Link Cancer Protein To Cholesterol

Animal Data Lead Researchers To Possible MG Therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...